 Connection
Atsushi Oba to Survival Rate
This is a "connection" page, showing publications Atsushi Oba has written about Survival Rate.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.688 |
|
|
|
-
Oba A, Wu YHA, Lieu CH, Meguid C, Colborn KL, Beaty L, Al-Musawi MH, Davis SL, Leal AD, Purcell T, King G, Wooten ES, Fujiwara Y, Goodman KA, Schefter T, Karam SD, Gleisner AL, Ahrendt S, Leong S, Messersmith WA, Schulick RD, Del Chiaro M. Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. Br J Surg. 2021 08 19; 108(8):976-982.
Score: 0.122
-
Oba A, Kudo A, Akahoshi K, Kishino M, Akashi T, Katsuta E, Iwao Y, Ono H, Mitsunori Y, Ban D, Tanaka S, Eishi Y, Tateishi U, Tanabe M. A simple morphological classification to estimate the malignant potential of pancreatic neuroendocrine tumors. J Gastroenterol. 2017 10; 52(10):1140-1146.
Score: 0.090
-
Oba A, Ban D, Kirimura S, Akahoshi K, Mitsunori Y, Matsumura S, Ochiai T, Kudo A, Tanaka S, Minoru T. Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. 2016 Aug; 23(8):480-8.
Score: 0.085
-
Tsybulskyi D, Hashimoto D, Tanaka K, Murotani K, Taguri M, Yamaki S, Sato S, Oba A, Inoue Y, Otsuka S, Ohgi K, Sugiura T, Shintakuya R, Okada K, Uemura K, Inoue K, Mizuma M, Unno M, Asano T, Nakagawa N, Takami H, Takahashi R, Motoi F, Akahoshi K, Ban D, Gulla A, Ishikawa H, Hirano S, Satoi S. Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression Model. J Hepatobiliary Pancreat Sci. 2026 Mar; 33(3):216-227.
Score: 0.041
-
Miyata T, Oba A, Kato T, Maekawa A, Tsuchiya S, Baba H, Tauchi J, Kobayashi K, Ono Y, Sasaki T, Ozaka M, Sasahira N, Ito H, Iwatsuki M, Matsueda K, Inoue Y, Takahashi Y. Surgical Challenges Associated with Collateral Veins Formation in Pancreatic Cancer with Vein Resection. Ann Surg Oncol. 2026 Apr; 33(4):3535-3544.
Score: 0.041
-
Shibata Y, Jansson H, Kobayashi K, Yu W, Oba A, Ghorbani P, Ono Y, D'Souza MA, Sturesson C, Ito H, Sparrelid E, Inoue Y, Gilg S, Takahashi Y. Assessing surgical resection in recurrent biliary tract cancer: International two-centre experience. Eur J Surg Oncol. 2026 Jan; 52(1):111159.
Score: 0.041
-
Omiya K, Oba A, Sugiura K, Maekawa A, Mie T, Kobayashi K, Ono Y, Sasaki T, Ozaka M, Sasahira N, Ito H, Inoue Y, Takahashi Y. Resectable Pancreatic Cancer with CA19-9 > 500 U/mL: A Biological Indicator for Survival Benefit with Intensive Neoadjuvant Chemotherapy. Ann Surg Oncol. 2025 Aug; 32(8):5411-5420.
Score: 0.039
-
Kobayashi K, Inoue Y, Oba A, Ono Y, Osumi H, Sato T, Ito H, Mise Y, Shinozaki E, Yamaguchi K, Saiura A, Takahashi Y. Strategies for Recurrent Colorectal Liver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of Multidisciplinary Treatment. Ann Surg Oncol. 2025 Mar; 32(3):1729-1741.
Score: 0.038
-
Sadamori H, Hasegawa K, Oba A, Kato Y, Soejima Y, Monden K, Umeda Y, Abe Y, Ko S, Saiura A, Ohtsuka M, Kubo S, Shirabe K, Nagano H, Fujiwara T, Nakamura M, Endo I. Short- and long-term outcomes of liver resection with hepatic vein reconstruction for liver tumors: A nationwide multicenter survey. J Hepatobiliary Pancreat Sci. 2024 Dec; 31(12):863-875.
Score: 0.038
-
Kiritani S, Ono Y, Takamatsu M, Yoshio S, Miyashita M, Oba A, Sato T, Ito H, Inoue Y, Saiura A, Takahashi Y. ASO Visual Abstract: Unique Biology of Pancreatic Ductal Adenocarcinoma Accompanied by Rapidly Impaired Diabetes: A Favorable Long-term Survival after Curative Resection. Ann Surg Oncol. 2024 Mar; 31(3):1944-1945.
Score: 0.036
-
Kiritani S, Ono Y, Takamatsu M, Yoshio S, Miyashita M, Oba A, Sato T, Ito H, Inoue Y, Saiura A, Takahashi Y. Unique Biology of Pancreatic Ductal Adenocarcinoma Accompanied by Rapidly Impaired Diabetes: A Favorable Long-Term Survival Following Curative Resection. Ann Surg Oncol. 2024 Jan; 31(1):514-524.
Score: 0.035
-
Machairas N, Raptis DA, Velázquez PS, Sauvanet A, Rueda de Leon A, Oba A, Koerkamp BG, Lovasik B, Chan C, Yeo CJ, Bassi C, Ferrone CR, Kooby D, Moskal D, Tamburrino D, Yoon DS, Barroso E, de Santibañes E, Kauffmann EF, Vigia E, Robin F, Casciani F, Burdío F, Belfiori G, Malleo G, Lavu H, Hartog H, Hwang HK, Han HS, Marques HP, Poves I, Domínguez-Rosado I, Park JS, Lillemoe KD, Roberts K, Sulpice L, Besselink MG, Abuawwad M, Del Chiaro M, de Santibañes M, Falconi M, D'Silva M, Silva M, Hilal MA, Qadan M, Sell NM, Beghdadi N, Napoli N, Busch ORC, Mazza O, Muiesan P, Müller PC, Ravikumar R, Schulick R, Powell-Brett S, Abbas SH, Mackay TM, Stoop TF, Gallagher TK, Boggi U, van Eijck C, Clavien PA, Conlon KCP, Fusai GK. The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis. Ann Surg. 2021 11 01; 274(5):721-728.
Score: 0.031
-
Akahoshi K, Ban D, Kuboki R, Oba A, Ono H, Mitsunori Y, Kudo A, Tanaka S, Tanabe M. Orotate phosphoribosyltransferase as a predictor of benefit from S-1 adjuvant chemotherapy for cholangiocarcinoma patients. J Gastroenterol Hepatol. 2019 Jun; 34(6):1108-1115.
Score: 0.025
-
Inoue Y, Saiura A, Oba A, Kawakatsu S, Ono Y, Sato T, Mise Y, Ishizawa T, Takahashi Y, Ito H. Optimal Extent of Superior Mesenteric Artery Dissection during Pancreaticoduodenectomy for Pancreatic Cancer: Balancing Surgical and Oncological Safety. J Gastrointest Surg. 2019 07; 23(7):1373-1383.
Score: 0.025
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|